A detailed history of Granite Investment Partners, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Granite Investment Partners, LLC holds 1,502,877 shares of FOLD stock, worth $14.7 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
1,502,877
Previous 821,178 83.01%
Holding current value
$14.7 Million
Previous $8.15 Million 97.03%
% of portfolio
0.71%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$9.55 - $12.09 $6.51 Million - $8.24 Million
681,699 Added 83.01%
1,502,877 $16.1 Million
Q2 2024

Aug 12, 2024

SELL
$9.04 - $11.75 $882,810 - $1.15 Million
-97,656 Reduced 10.63%
821,178 $8.15 Million
Q1 2024

May 13, 2024

BUY
$11.43 - $14.24 $10.5 Million - $13.1 Million
918,834 New
918,834 $10.8 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.